Katie A. Greenzang | Medical Services
Programs & Services
Languages
- English
Katie A. Greenzang | Education
Medical School
Columbia University, College of Physicians & Surgeons
2009, New York, NY
Internship
Pediatrics
University of Washington, Seattle Children’s Hospital
2010, Seattle, WA
Residency
Pediatrics
University of Washington, Seattle Children’s Hospital
2013, Seattle, WA
Fellowship
Pediatric Hematology-Oncology
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
2016, Boston, MA
Katie A. Greenzang | Certifications
- American Board of Pediatrics (General)
- American Board of Pediatrics (Hematology-Oncology)
Katie A. Greenzang | Publications
Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination. J Natl Cancer Inst. 2025 Mar 31. View Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination. Abstract
Help Navigate the Process: Early Information and Communication About Late Effects of Pediatric and Adolescent Cancer. JCO Oncol Pract. 2025 Mar 20; OP2400841. View Help Navigate the Process: Early Information and Communication About Late Effects of Pediatric and Adolescent Cancer. Abstract
Effective and Engaging Active Learning in the Medical School Classroom: Lessons from Case-Based Collaborative Learning. J Med Educ Curric Dev. 2025 Jan-Dec; 12:23821205251317149. View Effective and Engaging Active Learning in the Medical School Classroom: Lessons from Case-Based Collaborative Learning. Abstract
Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report. J Natl Cancer Inst. 2024 Oct 01; 116(10):1664-1674. View Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report. Abstract
'Blood and guts': Interleaving gastroenterology and haematology physiology. Med Educ. 2024 11; 58(11):1393-1394. View 'Blood and guts': Interleaving gastroenterology and haematology physiology. Abstract
Principles in the Development of Contemporary Treatment of Childhood Malignancies: The First 75 Years. Cold Spring Harb Perspect Med. 2024 Jul 15. View Principles in the Development of Contemporary Treatment of Childhood Malignancies: The First 75 Years. Abstract
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer. 2024 Nov 15; 130(22):3785-3796. View Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Abstract
"A very difficult conversation": Challenges and opportunities for improvement in pediatric oncology clinician communication about late effects. Pediatr Blood Cancer. 2024 Aug; 71(8):e31093. View "A very difficult conversation": Challenges and opportunities for improvement in pediatric oncology clinician communication about late effects. Abstract
Communicating neurocognitive impacts of childhood cancer: Engaging stakeholders to identify research priorities. Patient Educ Couns. 2023 11; 116:107935. View Communicating neurocognitive impacts of childhood cancer: Engaging stakeholders to identify research priorities. Abstract
Patient, Caregiver, and Clinician Perspectives on Core Components of Therapeutic Alliance for Adolescents and Young Adults With Advanced Cancer: A Qualitative Study. JAMA Netw Open. 2023 08 01; 6(8):e2328153. View Patient, Caregiver, and Clinician Perspectives on Core Components of Therapeutic Alliance for Adolescents and Young Adults With Advanced Cancer: A Qualitative Study. Abstract
Patient-Reported Outcomes in Pediatric Patients With Cancer. Am Soc Clin Oncol Educ Book. 2023 May; 43:e390272. View Patient-Reported Outcomes in Pediatric Patients With Cancer. Abstract
"There's no playbook for when your kid has cancer": Desired elements of an electronic resource to support pediatric cancer communication. Pediatr Blood Cancer. 2023 03; 70(3):e30198. View "There's no playbook for when your kid has cancer": Desired elements of an electronic resource to support pediatric cancer communication. Abstract
Profile Comparison of Patient-Reported and Proxy-Reported Symptoms in Pediatric Patients With Cancer Receiving Chemotherapy. JAMA Netw Open. 2022 03 01; 5(3):e221855. View Profile Comparison of Patient-Reported and Proxy-Reported Symptoms in Pediatric Patients With Cancer Receiving Chemotherapy. Abstract
Early parental knowledge of late effect risks in children with cancer. Pediatr Blood Cancer. 2022 02; 69(2):e29473. View Early parental knowledge of late effect risks in children with cancer. Abstract
The predictive trifecta? Fatigue, pain, and anxiety severity forecast the suffering profile of children with cancer. Support Care Cancer. 2022 Mar; 30(3):2081-2089. View The predictive trifecta? Fatigue, pain, and anxiety severity forecast the suffering profile of children with cancer. Abstract
Thinking ahead: Parents' worries about late effects of childhood cancer treatment. Pediatr Blood Cancer. 2021 12; 68(12):e29335. View Thinking ahead: Parents' worries about late effects of childhood cancer treatment. Abstract
"What Matters to Me": What pediatric stem cell transplant patients want their providers to know. J Psychosoc Oncol. 2021; 39(4):586-593. View "What Matters to Me": What pediatric stem cell transplant patients want their providers to know. Abstract
What, When, and Who: Optimizing Recruitment to Pediatric Pulmonology. ATS Sch. 2020 Dec 03; 1(4):337-339. View What, When, and Who: Optimizing Recruitment to Pediatric Pulmonology. Abstract
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatr Blood Cancer. 2020 10; 67(10):e28559. View The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Abstract
Early information needs of adolescents and young adults about late effects of cancer treatment. Cancer. 2020 07 15; 126(14):3281-3288. View Early information needs of adolescents and young adults about late effects of cancer treatment. Abstract
Parental Considerations Regarding Cure and Late Effects for Children With Cancer. Pediatrics. 2020 05; 145(5). View Parental Considerations Regarding Cure and Late Effects for Children With Cancer. Abstract
Communication during childhood cancer: Systematic review of patient perspectives. Cancer. 2020 02 15; 126(4):701-716. View Communication during childhood cancer: Systematic review of patient perspectives. Abstract
Completion of Adolescent Cancer Treatment: Excitement, Guilt, and Anxiety. Pediatrics. 2019 03; 143(3). View Completion of Adolescent Cancer Treatment: Excitement, Guilt, and Anxiety. Abstract
Patients of Our Own: Defining "Ownership" of Clinical Care in Graduate Medical Education. Teach Learn Med. 2019 Aug-Sep; 31(4):393-401. View Patients of Our Own: Defining "Ownership" of Clinical Care in Graduate Medical Education. Abstract
Parental distress and desire for information regarding long-term implications of pediatric cancer treatment. Cancer. 2018 12 01; 124(23):4529-4537. View Parental distress and desire for information regarding long-term implications of pediatric cancer treatment. Abstract
Parent understanding of the risk of future limitations secondary to pediatric cancer treatment. Pediatr Blood Cancer. 2018 07; 65(7):e27020. View Parent understanding of the risk of future limitations secondary to pediatric cancer treatment. Abstract
Parent perspectives on information about late effects of childhood cancer treatment and their role in initial treatment decision making. Pediatr Blood Cancer. 2018 06; 65(6):e26978. View Parent perspectives on information about late effects of childhood cancer treatment and their role in initial treatment decision making. Abstract
Hearing Loss. J Clin Oncol. 2018 01 01; 36(1):94-95. View Hearing Loss. Abstract
Longitudinal parental preferences for late effects communication during cancer treatment. Pediatr Blood Cancer. 2018 Jan; 65(1). View Longitudinal parental preferences for late effects communication during cancer treatment. Abstract
The Importance of Fostering Ownership During Medical Training: Working 9-5 Isn't the Only Issue. Am J Bioeth. 2016 09; 16(9):17-8. View The Importance of Fostering Ownership During Medical Training: Working 9-5 Isn't the Only Issue. Abstract
Parental preparedness for late effects and long-term quality of life in survivors of childhood cancer. Cancer. 2016 08 15; 122(16):2587-94. View Parental preparedness for late effects and long-term quality of life in survivors of childhood cancer. Abstract
Responsibility for Patient Care in Graduate Medical Education: Yours, Mine, or Ours? JAMA Pediatr. 2015 Nov; 169(11):987-8. View Responsibility for Patient Care in Graduate Medical Education: Yours, Mine, or Ours? Abstract
Task-switching in schizophrenia: active switching costs and passive carry-over effects in an antisaccade paradigm. Exp Brain Res. 2007 Aug; 181(3):493-502. View Task-switching in schizophrenia: active switching costs and passive carry-over effects in an antisaccade paradigm. Abstract
Switching, plasticity, and prediction in a saccadic task-switch paradigm. Exp Brain Res. 2006 Jan; 168(1-2):76-87. View Switching, plasticity, and prediction in a saccadic task-switch paradigm. Abstract